Intellia Therapeutics NTLA is currently advancing two late-stage in vivo pipeline candidates – nex-z (or, NTLA-2001) for ...

Korro Bio saw its stock reach all-time lows on disappointing data for its lead pipeline candidate, while Intellia Therapeutics saw analyst downgrades on safety concerns despite releasing positive data ...

Intellia Therapeutics, Inc. (NASDAQ:NTLA) is one of the best gene-editing stocks to buy according to hedge funds.

The Hero Vida Nex 3 EV Concept generates significant buzz as a potential four-wheeler entry. While many details remain under ...

National, November 20, 2025 - Lava International Limited, India’s fastest-growing homegrown smartphone manufacturer, has ...